Your browser doesn't support javascript.
loading
2020 ASCO, 2023 NCCN, 2023 MASCC/ESMO, and 2019 CCO: a comparison of antiemetic guidelines for the treatment of chemotherapy-induced nausea and vomiting in cancer patients.
Kennedy, Samantha K F; Goodall, Shannon; Lee, Shing Fung; DeAngelis, Carlo; Jocko, Allison; Charbonneau, Flay; Wang, Katie; Pasetka, Mark; Ko, Yoo-Joung; Wong, Henry C Y; Chan, Adrian Wai; Rajeswaran, Thenugaa; Gojsevic, Milena; Chow, Edward; Gralla, Richard J; Ng, Terry L; Jerzak, Katarzyna J.
Afiliación
  • Kennedy SKF; Odette Cancer Centre, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON, Canada. samantha.kennedy@uwaterloo.ca.
  • Goodall S; Department of Internal Medicine, Santa Barbara Cottage Hospital, Santa Barbara, CA, USA.
  • Lee SF; Department of Radiation Oncology, National University Cancer Institute, National University Hospital, Singapore, Singapore.
  • DeAngelis C; Department of Clinical Oncology, Tuen Mun Hospital, New Territories West Cluster, Hospital Authority, Tuen Mun, Hong Kong.
  • Jocko A; Odette Cancer Centre, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON, Canada.
  • Charbonneau F; Scarborough Health Network, Oncology Pharmacy, Toronto, ON, Canada.
  • Wang K; Odette Cancer Centre, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON, Canada.
  • Pasetka M; Odette Cancer Centre, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON, Canada.
  • Ko YJ; Odette Cancer Centre, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON, Canada.
  • Wong HCY; Oncology and Endoscopy, St Michael Hospital, Toronto, ON, Canada.
  • Chan AW; Department of Oncology, Princess Margaret Hospital, Kowloon, Hong Kong.
  • Rajeswaran T; Odette Cancer Centre, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON, Canada.
  • Gojsevic M; Odette Cancer Centre, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON, Canada.
  • Chow E; Odette Cancer Centre, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON, Canada.
  • Gralla RJ; Odette Cancer Centre, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON, Canada.
  • Ng TL; Albert Einstein College of Medicine, Jacobi Medical Center, Bronx, NY, USA.
  • Jerzak KJ; Division of Medical Oncology, Ottawa Hospital Research Institute, Department of Medicine, University of Ottawa, Ottawa, ON, Canada.
Support Care Cancer ; 32(5): 280, 2024 Apr 10.
Article en En | MEDLINE | ID: mdl-38594320
ABSTRACT
Chemotherapy-induced nausea and vomiting (CINV) is a common toxicity that may impair the quality of life of patients with various malignancies ranging from early to end stages. In light of frequent changes to the guidelines for optimal management of CINV, we undertook this narrative review to compare the most recent guidelines published by ASCO (2020), NCCN (2023), MASCC/ESMO (2023), and CCO (2019). The processes undertaken by each organization to evaluate existing literature were also described. Although ASCO, NCCN, MASCC/ESMO, and CCO guidelines for the treatment and prevention of CINV share many fundamental similarities, the literature surrounding low and minimal emetic risk regimens is lacking. Current data regarding adherence to these guidelines is poor and warrants further investigation to improve care.
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Antieméticos / Neoplasias / Antineoplásicos Límite: Humans Idioma: En Año: 2024 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Antieméticos / Neoplasias / Antineoplásicos Límite: Humans Idioma: En Año: 2024 Tipo del documento: Article